Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity?

Med Clin (Barc). 2020 Jul 10;155(1):23-25. doi: 10.1016/j.medcli.2020.04.004. Epub 2020 Apr 22.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antimalarials / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Global Health
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Antimalarials

Associated data

  • ClinicalTrials.gov/NCT04321278